Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders

Biochemical Pharmacology

Volumn 84, Issue 10, 2012, Pages 1340-1350

  Lee, Ha Na ^a   Surh, Young Joon ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Chronic inflammatory disease; Lipid mediator class switching; Macrophage; Resolution of inflammation; Resolvin

Indexed keywords

ACETYLSALICYLIC ACID; BRADYKININ; CYCLOOXYGENASE 2 INHIBITOR; DOCOSAHEXAENOIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HISTAMINE; ICOSANOID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPID; LIPOXIN; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PADGEM PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE; RESOLVIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTHMA; ATHEROSCLEROSIS; CELL FUNCTION; CELL MEMBRANE; CELL POLARITY; CHRONIC INFLAMMATION; COLITIS; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG EFFICACY; ENTERITIS; HUMAN; HYPERTENSION; INFLAMMATION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LIPOGENESIS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MACROPHAGE; MEDIATOR; MONOCYTE; MULTIPLE SCLEROSIS; NEOPLASM; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; TANDEM MASS SPECTROMETRY; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMANS; INFLAMMATION; NF-KAPPA B; SIGNAL TRANSDUCTION; STEREOISOMERISM;

EID: 84867855981     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.004     Document Type: Review

References (103)

1. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 2011 5922 5943
2. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
3. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
4. R. Rajakariar, M.M. Yaqoob, and D.W. Gilroy COX-2 in inflammation and resolution Mol Interv 6 2006 199 207
5. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat Immunol 6 2005 1191 1197
6. C. Nathan Neutrophils and immunity: challenges and opportunities Nat Rev Immunol 6 2006 173 182
7. Z. Bian, Y. Guo, B. Ha, K. Zen, and Y. Liu Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions J Immunol 188 2012 844 853
8. C.N. Serhan, S.D. Brain, C.D. Buckley, D.W. Gilroy, C. Haslett, and L.A. O'Neill Resolution of inflammation: state of the art, definitions and terms FASEB J 21 2007 325 332
9. 2, and PAF J Clin Invest 101 1998 890 898
10. M. Spite, and C.N. Serhan Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins Circ Res 107 2010 1170 1184
11. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, and G. Mirick Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 2002 1025 1037
12. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J Exp Med 192 2000 1197 1204
13. T. Lawrence, D.A. Willoughby, and D.W. Gilroy Anti-inflammatory lipid mediators and insights into the resolution of inflammation Nat Rev Immunol 2 2002 787 795
14. J. Savill, and V. Fadok Corpse clearance defines the meaning of cell death Nature 407 2000 784 788
15. C.L. Van Hove, T. Maes, G.F. Joos, and K.G. Tournoy Chronic inflammation in asthma: a contest of persistence vs resolution Allergy 63 2008 1095 1109
16. R.W. Vandivier, P.M. Henson, and I.S. Douglas Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease Chest 129 2006 1673 1682
17. G.J. Bellingan, P. Xu, H. Cooksley, H. Cauldwell, A. Shock, and S. Bottoms Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation J Exp Med 196 2002 1515 1521
18. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
19. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu Rev Immunol 25 2007 101 137
20. C.N. Serhan, and N. Chiang Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus Br J Pharmacol 153 Suppl. 1 2008 S200 S215
21. A.P. Simopoulos, A. Leaf, and N. Salem Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids J Am Coll Nutr 18 1999 487 489
22. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, and D.A. Willoughby Inducible cyclooxygenase may have anti-inflammatory properties Nat Med 5 1999 698 701
23. R.E. Voll, M. Herrmann, E.A. Roth, C. Stach, J.R. Kalden, and I. Girkontaite Immunosuppressive effects of apoptotic cells Nature 390 1997 350 351
24. H.A. Golpon, V.A. Fadok, L. Taraseviciene-Stewart, R. Scerbavicius, C. Sauer, and T. Welte Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth FASEB J 18 2004 1716 1718
25. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat Rev Immunol 10 2010 36 46
26. G.J. Bellingan, H. Caldwell, S.E. Howie, I. Dransfield, and C. Haslett In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes J Immunol 157 1996 2577 2585
27. M. Stein, S. Keshav, N. Harris, and S. Gordon Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation J Exp Med 176 1992 287 292
28. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
29. G. Lopez-Castejon, A. Baroja-Mazo, and P. Pelegrin Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules Cell Mol Life Sci 68 2011 3095 3107
30. J.I. Odegaard, R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, and L. Mukundan Macrophage-specific PPARγ controls alternative activation and improves insulin resistance Nature 447 2007 1116 1120
31. J.R. Nofer, M. Bot, M. Brodde, P.J. Taylor, P. Salm, and V. Brinkmann FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 115 2007 501 508
32. G. Schmitz, and J. Ecker The opposing effects of n-3 and n-6 fatty acids Prog Lipid Res 47 2008 147 155
33. C.N. Serhan, A. Jain, S. Marleau, C. Clish, A. Kantarci, and B. Behbehani Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators J Immunol 171 2003 6856 6865
34. D. Bagga, L. Wang, R. Farias-Eisner, J.A. Glaspy, and S.T. Reddy Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion Proc Natl Acad Sci USA 100 2003 1751 1756
35. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 2001 612 619
36. J.M. Schwab, and C.N. Serhan Lipoxins and new lipid mediators in the resolution of inflammation Curr Opin Pharmacol 6 2006 414 420
37. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
38. S. Khanna, S. Biswas, Y. Shang, E. Collard, A. Azad, and C. Kauh Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice PLoS ONE 5 2010 e9539
39. D.W. Gilroy, T. Lawrence, M. Perretti, and A.G. Rossi Inflammatory resolution: new opportunities for drug discovery Nat Rev Drug Discov 3 2004 401 416
40. D.A. Willoughby, A.R. Moore, P.R. Colville-Nash, and D. Gilroy Resolution of inflammation Int J Immunopharmacol 22 2000 1131 1135
41. G.L. Bannenberg, N. Chiang, A. Ariel, M. Arita, E. Tjonahen, and K.H. Gotlinger Molecular circuits of resolution: formation and actions of resolvins and protectins J Immunol 174 2005 4345 4355
42. 1 J Exp Med 201 2005 713 722
43. C.N. Serhan Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators J Periodontol 79 2008 1520 1526
44. S.F. Oh, P.S. Pillai, A. Recchiuti, R. Yang, and C.N. Serhan Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation J Clin Invest 121 2011 569 581
45. E. Tjonahen, S.F. Oh, J. Siegelman, S. Elangovan, K.B. Percarpio, and S. Hong Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis Chem Biol 13 2006 1193 1202
46. 1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 2007 9323 9334
47. N. Chiang, G. Fredman, F. Backhed, S.F. Oh, T. Vickery, and B.A. Schmidt Infection regulates pro-resolving mediators that lower antibiotic requirements Nature 484 2012 524 528
48. S. Hong, K. Gronert, P.R. Devchand, R.L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J Biol Chem 278 2003 14677 14687
49. C.N. Serhan, S. Hong, and Y. Lu Lipid mediator informatics-lipidomics: novel pathways in mapping resolution AAPS J 8 2006 E284 E297
50. C.N. Serhan, R. Yang, K. Martinod, K. Kasuga, P.S. Pillai, and T.F. Porter Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J Exp Med 206 2009 15 23
51. M. Arita, T. Ohira, Y.P. Sun, S. Elangovan, N. Chiang, and C.N. Serhan Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation J Immunol 178 2007 3912 3917
52. K. Gronert, A. Kantarci, B.D. Levy, C.B. Clish, S. Odparlik, and H. Hasturk A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage J Immunol 172 2004 1856 1861
53. H. Hasturk, A. Kantarci, T. Ohira, M. Arita, N. Ebrahimi, and N. Chiang RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis FASEB J 20 2006 401 403
54. A. Ariel, G. Fredman, Y.P. Sun, A. Kantarci, T.E. Van Dyke, and A.D. Luster Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression Nat Immnunol 7 2006 1209 1216
55. E. Titos, B. Rius, A. Gonzalez-Periz, C. Lopez-Vicario, E. Moran-Salvador, and M. Martinez-Clemente Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype J Immunol 187 2011 5408 5418
56. O. Odusanwo, S. Chinthamani, A. McCall, M.E. Duffey, and O.J. Baker Resolvin D1 prevents TNF-alpha-mediated disruption of salivary epithelial formation Am J Physiol Cell Physiol 302 2012 C1331 C1345
57. P.K. Mukherjee, V.L. Marcheselli, C.N. Serhan, and N.G. Bazan Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress Proc Natl Acad Sci USA 101 2004 8491 8496
58. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, and R. Yang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc Natl Acad Sci USA 107 2010 1660 1665
59. 1 limits polymorphonuclear leukocytes recruitment to inflammatory loci: receptor-dependent actions Arterioscler Thromb Vasc Biol 32 2012 1970 1978
60. 1 J Neurosci 31 2011 18433 18438
61. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 2001 7 11
62. T. Ishida, M. Yoshida, M. Arita, Y. Nishitani, S. Nishiumi, and A. Masuda Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis Inflamm Bowel Dis 16 2010 87 95
63. B. Wang, X. Gong, J.Y. Wan, L. Zhang, Z. Zhang, and H.Z. Li Resolvin D1 protects mice from LPS-induced acute lung injury Pulm Pharmacol Ther 24 2011 434 441
64. Z. Han, D.L. Boyle, A.M. Manning, and G.S. Firestein AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis Autoimmunity 28 1998 197 208
65. L.A. Hart, V.L. Krishnan, I.M. Adcock, P.J. Barnes, and K.F. Chung Activation and localization of transcription factor, nuclear factor-kappaB, in asthma Am J Respir Crit Care Med 158 1998 1585 1592
66. A.P. Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J Am Coll Nutr 21 2002 495 505
67. A.P. Simopoulos The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases Exp Biol Med (Maywood) 233 2008 674 688
68. K.M. Connor, J.P. SanGiovanni, C. Lofqvist, C.M. Aderman, J. Chen, and A. Higuchi Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis Nat Med 13 2007 868 873
69. J.M. Dogne, J. Hanson, C. Supuran, and D. Pratico Coxibs and cardiovascular side-effects: from light to shadow Curr Pharm Des 12 2006 971 975
70. C.H. Lee Resolvins as new fascinating drug candidates for inflammatory diseases Arch Pharm Res 35 2012 3 7
71. V.R. Krishnamurthy, A. Dougherty, C.A. Haller, and E.L. Chaikof Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid J Org Chem 76 2011 5433 5437
72. A. Ariel, and C.N. Serhan Resolvins and protectins in the termination program of acute inflammation Trends Immunol 28 2007 176 183
73. S. Schif-Zuck, N. Gross, S. Assi, R. Rostoker, C.N. Serhan, and A. Ariel Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids Eur J Immunol 41 2011 366 379
74. 1 PLoS ONE 6 2011 e24422
75. 1 induce apoptosis of activated CD4+ T cells J Immunol 181 2008 4534 4544
76. 1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo J Immunol 179 2007 7021 7029
77. 1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye Cornea 2012 10.1097/ICO.0b013e31823f789e
78. 1 improves tear production and decreases inflammation in a dry eye mouse model J Ocul Pharmacol Ther 26 2010 431 439
79. 1 in the timely resolution of allergic airway inflammation J Immunol 186 2011 6129 6135
80. T. Ishizuka, T. Hisada, H. Aoki, and M. Mori Resolvin E1: a novel lipid mediator in the resolution of allergic airway inflammation Expert Rev Clin Immunol 4 2008 669 672
81. 4 to promote the resolution of allergic airway inflammation Nat Immunol 9 2008 873 879
82. 1 J Immunol 186 2011 1735 1746
83. 1 on the development of asthmatic airway inflammation Biochem Biophys Res Commun 400 2010 128 133
84. 1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma Biochem Biophys Res Commun 367 2008 509 515
85. 1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification Proc Natl Acad Sci USA 107 2010 14298 14303
86. 1 protects the rat heart against reperfusion injury Am J Physiol Heart Circ Physiol 299 2010 H153 H164
87. 1 attenuate inflammatory pain via central and peripheral actions Nat Med 16 2010 592 597 1p following 7
88. 1 protects mice from bacterial pneumonia and acute lung injury J Immunol 184 2010 836 843
89. 2 Org Lett 11 2009 3602 3605
90. 2 formation and impact in inflammation resolution J Immunol 188 2012 4527 4534
91. Y. Isobe, M. Arita, S. Matsueda, R. Iwamoto, T. Fujihara, and H. Nakanishi Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid J Biol Chem 287 2012 10525 10534
92. L.V. Norling, M. Spite, R. Yang, R.J. Flower, M. Perretti, and C.N. Serhan Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing J Immunol 186 2011 5543 5547
93. 1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice FASEB J 25 2011 2399 2407
94. 1 Pain 152 2011 557 565
95. 1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception Br J Pharmacol 165 2012 683 692
96. 2 prevent experimental colitis in mice J Immunol 187 2011 1957 1969
97. Z.Z. Xu, and R.R. Ji Resolvins are potent analgesics for arthritic pain Br J Pharmacol 164 2011 274 277
98. 1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats Br J Pharmacol 164 2011 278 293
99. 2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
100. V.L. Marcheselli, S. Hong, W.J. Lukiw, X.H. Tian, K. Gronert, and A. Musto Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression J Biol Chem 278 2003 43807 43817
101. A. Gonzalez-Periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong, and E. Moran-Salvador Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins FASEB J 23 2009 1946 1957
102. J.S. Duffield, S. Hong, V.S. Vaidya, Y. Lu, G. Fredman, and C.N. Serhan Resolvin D series and protectin D1 mitigate acute kidney injury J Immunol 177 2006 5902 5911
103. C.N. Serhan, J. Dalli, S. Karamnov, A. Choi, C.K. Park, and Z.Z. Xu Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain FASEB J 26 2012 1755 1765